Edition:
India

Formycon AG (FYB.DE)

FYB.DE on Xetra

32.29EUR
21 Nov 2017
Change (% chg)

€0.12 (+0.36%)
Prev Close
€32.18
Open
€32.28
Day's High
€32.42
Day's Low
€32.07
Volume
2,467
Avg. Vol
9,745
52-wk High
€39.38
52-wk Low
€17.77

Chart for

About

Formycon AG is a Germany-based company engaged in the development of biological therapeutics. The Company's business activities are focused on the development and marketing of biopharmaceuticals that are similar to existing drugs, for which the patent protection is expiring, as well as the provision of contract services. It is... (more)

Overall

Beta: 1.67
Market Cap(Mil.): €347.03
Shares Outstanding(Mil.): 9.34
Dividend: --
Yield (%): --

Financials

BRIEF-Formycon confirms management board members until mid-2022

* DGAP-NEWS: FORMYCON AG: FORMYCON SETS COURSE FOR THE FUTURE AND CONFIRMS MANAGEMENT BOARD MEMBERS UNTIL MID-2022

16 Nov 2017

BRIEF-Formycon H1 loss widens to 2.88 million euros

* CLINICAL PHASE III STUDY WITH FYB201 CONTINUES ACCORDING TO PLAN‍​

29 Sep 2017

BRIEF-Formycon signs term sheet for development of FYB202

* SIGNS TERM SHEET FOR DEVELOPMENT OF FYB202 AND CARRIES OUT CAPITAL INCREASE

24 Jul 2017

BRIEF-Formycon Q1 EBITDA loss widens to 0.51 million euros

* Q1 ‍SALES REVENUES AND OTHER EARNINGS TOTALED EURO 3.38 MILLION (PREVIOUS YEAR: EURO 6.34 MILLION)​

30 May 2017

Earnings vs. Estimates